Suppr超能文献

钙、细胞衰老与帕金森病中的选择性神经元易损性。

Calcium, cellular aging, and selective neuronal vulnerability in Parkinson's disease.

机构信息

Department of Physiology, Feinberg School of Medicine, Northwestern University, 303 E. Chicago Ave., Chicago, IL 60611, USA.

出版信息

Cell Calcium. 2010 Feb;47(2):175-82. doi: 10.1016/j.ceca.2009.12.003. Epub 2010 Jan 6.

Abstract

Parkinson's disease (PD) is the second most common neurodegenerative disease in developed countries. The core motor symptoms are attributable to the degeneration of dopamine (DA) neurons in the substantia nigra pars compacta (SNc). Why these neurons, and other restricted sets of non-dopamine neuron, succumb in PD is not clear. One potential clue has come from the observation that the engagement of L-type Ca2+ channels during autonomous pacemaking elevates the sensitivity of SNc DA neurons to mitochondrial toxins used to create animal models of PD, suggesting that Ca2+ entry is a factor in their selective vulnerability. Epidemiological data also supports a linkage between L-type Ca2+ channels and the risk of developing PD. This review examines the hypothesis that the primary factor driving neurodegenerative changes in PD is the metabolic stress created by sustained Ca2+ entry, particularly in the face of genetic or environmental factors that compromise oxidative defenses or proteostatic competence.

摘要

帕金森病(PD)是发达国家第二常见的神经退行性疾病。核心运动症状归因于黑质致密部(SNc)中多巴胺(DA)神经元的退化。为什么这些神经元以及其他受限制的非多巴胺神经元会在 PD 中屈服尚不清楚。一个潜在的线索来自于这样一个观察结果,即在自主起搏过程中 L 型 Ca2+通道的参与会提高 SNc DA 神经元对用于创建 PD 动物模型的线粒体毒素的敏感性,这表明 Ca2+内流是其选择性易感性的一个因素。流行病学数据也支持 L 型 Ca2+通道与 PD 发病风险之间的联系。这篇综述探讨了这样一个假设,即驱动 PD 神经退行性变化的主要因素是持续 Ca2+内流引起的代谢应激,尤其是在遗传或环境因素损害氧化防御或蛋白质稳态能力的情况下。

相似文献

1
Calcium, cellular aging, and selective neuronal vulnerability in Parkinson's disease.
Cell Calcium. 2010 Feb;47(2):175-82. doi: 10.1016/j.ceca.2009.12.003. Epub 2010 Jan 6.
2
The role of calcium and mitochondrial oxidant stress in the loss of substantia nigra pars compacta dopaminergic neurons in Parkinson's disease.
Neuroscience. 2011 Dec 15;198:221-31. doi: 10.1016/j.neuroscience.2011.08.045. Epub 2011 Aug 25.
3
What causes the death of dopaminergic neurons in Parkinson's disease?
Prog Brain Res. 2010;183:59-77. doi: 10.1016/S0079-6123(10)83004-3.
4
Calcium homeostasis, selective vulnerability and Parkinson's disease.
Trends Neurosci. 2009 May;32(5):249-56. doi: 10.1016/j.tins.2009.01.006. Epub 2009 Mar 21.
5
The origins of oxidant stress in Parkinson's disease and therapeutic strategies.
Antioxid Redox Signal. 2011 Apr 1;14(7):1289-301. doi: 10.1089/ars.2010.3521. Epub 2010 Dec 15.
7
Cav1.3 channels control D2-autoreceptor responses via NCS-1 in substantia nigra dopamine neurons.
Brain. 2014 Aug;137(Pt 8):2287-302. doi: 10.1093/brain/awu131. Epub 2014 Jun 16.
8
Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1.
Nature. 2010 Dec 2;468(7324):696-700. doi: 10.1038/nature09536. Epub 2010 Nov 10.

引用本文的文献

2
Parallel Gene Expression Changes in Ventral Midbrain Dopamine and GABA Neurons during Normal Aging.
eNeuro. 2025 May 29;12(5). doi: 10.1523/ENEURO.0107-25.2025. Print 2025 May.
3
The impact of rs4698412 variant on Parkinson's disease progression in a longitudinal study.
Front Aging Neurosci. 2025 Apr 16;17:1570347. doi: 10.3389/fnagi.2025.1570347. eCollection 2025.
6
Nesfatin-1: A Biomarker and Potential Therapeutic Target in Neurological Disorders.
Neurochem Res. 2024 Jan;49(1):38-51. doi: 10.1007/s11064-023-04037-0. Epub 2023 Sep 23.
7
Tonic Activation of NR2D-Containing NMDARs Exacerbates Dopaminergic Neuronal Loss in MPTP-Injected Parkinsonian Mice.
J Neurosci. 2023 Nov 15;43(46):7730-7744. doi: 10.1523/JNEUROSCI.1955-22.2023. Epub 2023 Sep 19.
9
Calcium dysregulation combined with mitochondrial failure and electrophysiological maturity converge in Parkinson's iPSC-dopamine neurons.
iScience. 2023 Jun 7;26(7):107044. doi: 10.1016/j.isci.2023.107044. eCollection 2023 Jul 21.
10
Riddles in the dark: Decoding the relationship between neuromelanin and neurodegeneration in locus coeruleus neurons.
Neurosci Biobehav Rev. 2023 Sep;152:105287. doi: 10.1016/j.neubiorev.2023.105287. Epub 2023 Jun 15.

本文引用的文献

1
L-type calcium channel blockers and Parkinson disease in Denmark.
Ann Neurol. 2010 May;67(5):600-6. doi: 10.1002/ana.21937.
2
3
Robust pacemaking in substantia nigra dopaminergic neurons.
J Neurosci. 2009 Sep 2;29(35):11011-9. doi: 10.1523/JNEUROSCI.2519-09.2009.
4
DJ-1 and prevention of oxidative stress in Parkinson's disease and other age-related disorders.
Free Radic Biol Med. 2009 Nov 15;47(10):1354-61. doi: 10.1016/j.freeradbiomed.2009.08.003. Epub 2009 Aug 14.
6
Calcium signaling and neurodegenerative diseases.
Trends Mol Med. 2009 Mar;15(3):89-100. doi: 10.1016/j.molmed.2009.01.001. Epub 2009 Feb 21.
8
Mitofusin 2 tethers endoplasmic reticulum to mitochondria.
Nature. 2008 Dec 4;456(7222):605-10. doi: 10.1038/nature07534.
9
Expression and 1,4-dihydropyridine-binding properties of brain L-type calcium channel isoforms.
Mol Pharmacol. 2009 Feb;75(2):407-14. doi: 10.1124/mol.108.049981. Epub 2008 Nov 24.
10
A potential reservoir of immature dopaminergic replacement neurons in the adult mammalian olfactory bulb.
Pflugers Arch. 2009 Feb;457(4):899-915. doi: 10.1007/s00424-008-0535-0. Epub 2008 Nov 15.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验